WHWK
Whitehawk Therapeutics, Inc.
Price Chart
Latest Quote
$2.88
Current Price| Previous Close | $2.70 |
| Open | $2.74 |
| Day High | $2.95 |
| Day Low | $2.65 |
| Volume | 235,564 |
Stock Information
| Shares Outstanding | 47.13M |
| Cash Equivalents | $162.60M |
| Revenue | $14.38M |
| Net Income | $-15.62M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $135.73M |
| EPS (TTM) | $-0.64 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 24/42| Debt to Equity | 0.02 |
| Debt to Earnings | 0.04 |
| Current Ratio | 3.59 |
| Quick Ratio | 3.11 |
| Avg Revenue Growth | 624.58% |
| Profit Margin | -245.13% |
| Return on Equity | -121.37% |
| Avg FCF Growth | 43.10% |
| FCF Yield | -45.09% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $2.88 | 241,000 |
| 2026-01-30 | $2.70 | 65,500 |
| 2026-01-29 | $2.69 | 66,700 |
| 2026-01-28 | $2.70 | 46,400 |
| 2026-01-27 | $2.78 | 130,900 |
| 2026-01-26 | $2.68 | 64,700 |
| 2026-01-23 | $2.70 | 70,300 |
| 2026-01-22 | $2.85 | 123,900 |
| 2026-01-21 | $2.78 | 63,600 |
| 2026-01-20 | $2.86 | 114,600 |
| 2026-01-16 | $2.91 | 150,800 |
| 2026-01-15 | $2.79 | 88,600 |
| 2026-01-14 | $2.90 | 333,400 |
| 2026-01-13 | $2.75 | 185,200 |
| 2026-01-12 | $2.57 | 138,700 |
| 2026-01-09 | $2.64 | 86,100 |
| 2026-01-08 | $2.71 | 82,700 |
| 2026-01-07 | $2.67 | 114,800 |
| 2026-01-06 | $2.52 | 58,500 |
| 2026-01-05 | $2.53 | 84,500 |
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
đ° Latest News
Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention
Zacks âĸ 2026-01-21T12:57:00Z
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal
Insider Monkey âĸ 2026-01-13T12:48:28Z
Hedge funds investors own a significant stake of 37% in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK)
Simply Wall St. âĸ 2025-11-01T12:37:14Z
Tempus AI-Whitehawk Therapeutics Data Partnership Could Be a Game Changer for Tempus AI (TEM)
Simply Wall St. âĸ 2025-10-28T15:09:57Z
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
Zacks âĸ 2025-10-17T13:45:00Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $3,024,000 | $2,809,000 | $1,335,000 | $0 |
| Cost Of Revenue | $3,024,000 | $2,809,000 | $1,335,000 | $0 |
| Total Revenue | $25,983,000 | $24,354,000 | $15,216,000 | $1,000,000 |
| Operating Revenue | $25,983,000 | $24,354,000 | $15,216,000 | $1,000,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $154,000 | $231,000 | $230,000 | $665,000 |
| Total Expenses | $90,803,000 | $96,287,000 | $74,173,000 | $38,061,000 |
| Other Income Expense | $-2,642,000 | $-1,000 | $-3,724,000 | $-72,375,000 |
| Net Non Operating Interest Income Expense | $3,771,000 | $6,169,000 | $2,168,000 | $-652,000 |
| Interest Expense Non Operating | $154,000 | $231,000 | $230,000 | $665,000 |
| Operating Expense | $87,779,000 | $93,478,000 | $72,838,000 | $38,061,000 |
| Other Non Operating Income Expenses | - | - | - | $1,585,000 |
| Other Operating Expenses | - | - | - | $-120,000 |
| General And Administrative Expense | - | - | - | $18,511,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Net Interest Income | $3,771,000 | $6,169,000 | $2,168,000 | $-652,000 |
| Interest Income | $3,925,000 | $6,400,000 | $2,398,000 | $13,000 |
| Normalized Income | $-61,049,000 | $-65,764,000 | $-56,789,000 | $-56,099,200 |
| Net Income From Continuing And Discontinued Operation | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Total Operating Income As Reported | $-67,458,000 | $-71,933,000 | $-62,681,000 | $-111,217,000 |
| Net Income Common Stockholders | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,737,000 |
| Net Income | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Net Income Including Noncontrolling Interests | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Net Income Continuous Operations | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Pretax Income | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,088,000 |
| Special Income Charges | $-2,638,000 | $0 | $-3,724,000 | $-73,960,000 |
| Interest Income Non Operating | $3,925,000 | $6,400,000 | $2,398,000 | $13,000 |
| Operating Income | $-64,820,000 | $-71,933,000 | $-58,957,000 | $-37,061,000 |
| Gross Profit | $22,959,000 | $21,545,000 | $13,881,000 | $1,000,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Basic EPS | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-19,969,200 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-60,702,000 | $-65,364,000 | $-56,400,000 | $-35,358,000 |
| Total Unusual Items | $-2,642,000 | $-1,000 | $-3,724,000 | $-73,960,000 |
| Total Unusual Items Excluding Goodwill | $-2,642,000 | $-1,000 | $-3,724,000 | $-73,960,000 |
| Reconciled Depreciation | $193,000 | $169,000 | $159,000 | $105,000 |
| EBITDA (Bullshit earnings) | $-63,344,000 | $-65,365,000 | $-60,124,000 | $-109,318,000 |
| EBIT | $-63,537,000 | $-65,534,000 | $-60,283,000 | $-109,423,000 |
| Diluted Average Shares | $27,029,942 | $26,917,967 | $22,511,237 | $8,923,369 |
| Basic Average Shares | $27,029,942 | $26,917,967 | $22,511,237 | $8,923,369 |
| Diluted NI Availto Com Stockholders | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,737,000 |
| Tax Provision | $0 | $0 | $0 | $2,000 |
| Restructuring And Mergern Acquisition | $2,638,000 | $0 | - | - |
| Gain On Sale Of Security | $-4,000 | $-1,000 | - | - |
| Research And Development | $51,030,000 | $48,929,000 | $32,662,000 | $19,670,000 |
| Selling General And Administration | $36,749,000 | $44,549,000 | $40,176,000 | $18,511,000 |
| Impairment Of Capital Assets | - | $0 | $3,724,000 | $74,156,000 |
| Preferred Stock Dividends | - | - | - | $647,000 |
| Other Special Charges | - | - | - | $-196,000 |
| Other Gand A | - | - | - | $18,511,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $52,478,000 | $105,195,000 | $158,378,000 | $132,595,000 |
| Total Assets | $70,319,000 | $132,423,000 | $184,237,000 | $157,910,000 |
| Total Non Current Assets | $9,032,000 | $7,837,000 | $4,208,000 | $6,638,000 |
| Other Non Current Assets | $1,399,000 | $1,866,000 | $2,178,000 | $2,213,000 |
| Current Assets | $61,287,000 | $124,586,000 | $180,029,000 | $151,272,000 |
| Other Current Assets | $2,836,000 | $3,826,000 | $3,746,000 | $2,283,000 |
| Inventory | $5,311,000 | $6,427,000 | $1,861,000 | $0 |
| Receivables | $5,903,000 | $5,488,000 | $1,862,000 | $0 |
| Accounts Receivable | $5,903,000 | $5,488,000 | $1,862,000 | $0 |
| Allowance For Doubtful Accounts Receivable | $-100,000 | $-200,000 | - | - |
| Gross Accounts Receivable | $6,003,000 | $5,688,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $47,237,000 | $108,845,000 | $172,560,000 | $148,989,000 |
| Cash And Cash Equivalents | $28,670,000 | $62,888,000 | $39,019,000 | $148,989,000 |
| Goodwill And Other Intangible Assets | - | - | $0 | $3,811,000 |
| Other Intangible Assets | - | - | - | $3,811,000 |
| Prepaid Assets | - | - | - | $2,283,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $833,000 | $1,267,000 | $1,661,000 | $605,000 |
| Long Term Debt And Capital Lease Obligation | $565,000 | $833,000 | $1,267,000 | $474,000 |
| Current Debt And Capital Lease Obligation | $268,000 | $434,000 | $394,000 | $131,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $17,841,000 | $27,228,000 | $25,859,000 | $21,504,000 |
| Total Non Current Liabilities Net Minority Interest | $767,000 | $833,000 | $7,024,000 | $6,231,000 |
| Other Non Current Liabilities | $202,000 | - | - | - |
| Current Liabilities | $17,074,000 | $26,395,000 | $18,835,000 | $15,273,000 |
| Payables And Accrued Expenses | $16,742,000 | $22,880,000 | $12,978,000 | $13,677,000 |
| Payables | $2,159,000 | $11,655,000 | $3,519,000 | $6,439,000 |
| Accounts Payable | $2,159,000 | $5,898,000 | $3,519,000 | $6,439,000 |
| Tradeand Other Payables Non Current | - | $0 | $0 | $0 |
| Other Payable | - | $5,757,000 | - | - |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $52,478,000 | $105,195,000 | $158,378,000 | $136,406,000 |
| Total Equity Gross Minority Interest | $52,478,000 | $105,195,000 | $158,378,000 | $136,406,000 |
| Stockholders Equity | $52,478,000 | $105,195,000 | $158,378,000 | $136,406,000 |
| Gains Losses Not Affecting Retained Earnings | $16,000 | $27,000 | $-115,000 | $0 |
| Other Equity Adjustments | $16,000 | $27,000 | $-115,000 | - |
| Retained Earnings | $-332,654,000 | $-268,963,000 | $-203,198,000 | $-142,685,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $24,680,708 | $24,554,205 | $24,435,007 | $20,894,695 |
| Share Issued | $24,680,708 | $24,554,205 | $24,435,007 | $20,894,695 |
| Tangible Book Value | $52,478,000 | $105,195,000 | $158,378,000 | $132,595,000 |
| Invested Capital | $52,478,000 | $105,195,000 | $158,378,000 | $136,406,000 |
| Working Capital | $44,213,000 | $98,191,000 | $161,194,000 | $135,999,000 |
| Capital Lease Obligations | $833,000 | $1,267,000 | $1,661,000 | $605,000 |
| Total Capitalization | $52,478,000 | $105,195,000 | $158,378,000 | $136,406,000 |
| Additional Paid In Capital | $385,114,000 | $374,129,000 | $361,689,000 | $279,089,000 |
| Capital Stock | $2,000 | $2,000 | $2,000 | $2,000 |
| Common Stock | $2,000 | $2,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $565,000 | $833,000 | $1,267,000 | $474,000 |
| Current Capital Lease Obligation | $268,000 | $434,000 | $394,000 | $131,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $64,000 | $3,081,000 | $5,463,000 | $1,465,000 |
| Current Accrued Expenses | $14,583,000 | $11,225,000 | $9,459,000 | $7,238,000 |
| Net PPE | $7,633,000 | $5,971,000 | $2,030,000 | $614,000 |
| Accumulated Depreciation | $-463,000 | $-270,000 | $-101,000 | $-30,000 |
| Gross PPE | $8,096,000 | $6,241,000 | $2,131,000 | $644,000 |
| Leases | $133,000 | $129,000 | $129,000 | $0 |
| Construction In Progress | $6,590,000 | $4,389,000 | $77,000 | $0 |
| Other Properties | $51,000 | $25,000 | $1,522,000 | $557,000 |
| Machinery Furniture Equipment | $535,000 | $529,000 | $403,000 | $87,000 |
| Buildings And Improvements | $787,000 | $1,169,000 | $1,522,000 | - |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,778,000 | $421,000 | $917,000 | - |
| Work In Process | $0 | $1,366,000 | $0 | - |
| Raw Materials | $3,533,000 | $4,640,000 | $944,000 | - |
| Other Short Term Investments | $18,567,000 | $45,957,000 | $133,541,000 | $0 |
| Dueto Related Parties Non Current | - | $0 | $5,757,000 | $5,757,000 |
| Dueto Related Parties Current | - | $5,757,000 | $0 | $258,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-61,204,000 | $-63,635,000 | $-50,084,000 | $-22,469,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-59,550,000 | $-59,663,000 | $-49,640,000 | $-22,423,000 |
| Cash Flow From Continuing Operating Activities | $-59,550,000 | $-59,663,000 | $-49,640,000 | $-22,423,000 |
| Operating Gains Losses | - | - | - | $-196,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-1,654,000 | $-3,972,000 | $-444,000 | $-46,000 |
| Investing Cash Flow | $25,202,000 | $83,206,000 | $-132,886,000 | $25,153,000 |
| Cash Flow From Continuing Investing Activities | $25,202,000 | $83,206,000 | $-132,886,000 | $25,153,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $130,000 | $326,000 | $72,620,000 | $141,804,000 |
| Cash Flow From Continuing Financing Activities | $130,000 | $326,000 | $72,620,000 | $141,804,000 |
| Net Other Financing Charges | $-16,000 | $-160,000 | $-659,000 | $-9,617,000 |
| Issuance Of Capital Stock | - | $0 | $72,500,000 | $155,000,000 |
| Net Common Stock Issuance | - | $0 | $72,500,000 | $155,000,000 |
| Common Stock Issuance | - | $0 | $72,500,000 | $155,000,000 |
| Cash Dividends Paid | - | - | $0 | $-4,412,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Paid Supplemental Data | $211,000 | $230,000 | $230,000 | $22,000 |
| End Cash Position | $28,734,000 | $62,952,000 | $39,083,000 | $148,989,000 |
| Beginning Cash Position | $62,952,000 | $39,083,000 | $148,989,000 | $4,455,000 |
| Changes In Cash | $-34,218,000 | $23,869,000 | $-109,906,000 | $144,534,000 |
| Proceeds From Stock Option Exercised | $146,000 | $486,000 | $779,000 | $833,000 |
| Net Investment Purchase And Sale | $26,856,000 | $87,178,000 | $-132,442,000 | $0 |
| Sale Of Investment | $63,338,000 | $151,617,000 | $12,750,000 | $0 |
| Purchase Of Investment | $-36,482,000 | $-64,439,000 | $-145,192,000 | $0 |
| Net PPE Purchase And Sale | $-1,654,000 | $-3,972,000 | $-444,000 | $-46,000 |
| Purchase Of PPE | $-1,654,000 | $-3,972,000 | $-444,000 | $-46,000 |
| Change In Working Capital | $-6,050,000 | $-3,404,000 | $-1,820,000 | $12,245,000 |
| Change In Other Current Liabilities | $-310,000 | $-502,000 | $-291,000 | $-8,509,000 |
| Change In Other Current Assets | $518,000 | $518,000 | $437,000 | $481,000 |
| Change In Payables And Accrued Expense | $-9,773,000 | $-132,000 | $3,220,000 | $8,290,000 |
| Change In Prepaid Assets | $2,814,000 | $3,603,000 | $-1,463,000 | $-2,166,000 |
| Change In Inventory | $1,116,000 | $-3,265,000 | $-1,861,000 | $0 |
| Change In Receivables | $-415,000 | $-3,626,000 | $-1,862,000 | $14,149,000 |
| Changes In Account Receivables | $-415,000 | $-3,626,000 | $-1,862,000 | $14,149,000 |
| Other Non Cash Items | $460,000 | $519,000 | $382,000 | $836,000 |
| Stock Based Compensation | $10,839,000 | $11,954,000 | $9,643,000 | $2,106,000 |
| Amortization Of Securities | $-1,301,000 | $-3,136,000 | $-1,215,000 | $0 |
| Depreciation Amortization Depletion | $193,000 | $169,000 | $159,000 | $105,000 |
| Depreciation And Amortization | $193,000 | $169,000 | $159,000 | $105,000 |
| Net Income From Continuing Operations | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 |
| Asset Impairment Charge | - | $0 | $3,724,000 | $74,156,000 |
| Net Business Purchase And Sale | - | - | $0 | $25,199,000 |
| Sale Of Business | - | - | $0 | $29,700,000 |
| Purchase Of Business | - | - | $0 | $-4,501,000 |
| Unrealized Gain Loss On Investment Securities | - | - | $0 | $-1,585,000 |
| Issuance Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Change In Payable | - | - | - | $-90,000 |
| Change In Account Payable | - | - | - | $8,290,000 |